Your browser doesn't support javascript.
loading
Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial.
Jerusalem, Guy; de Boer, Richard H; Hurvitz, Sara; Yardley, Denise A; Kovalenko, Elena; Ejlertsen, Bent; Blau, Sibel; Özgüroglu, Mustafa; Landherr, László; Ewertz, Marianne; Taran, Tetiana; Fan, Jenna; Noel-Baron, Florence; Louveau, Anne-Laure; Burris, Howard.
Afiliação
  • Jerusalem G; CHU Sart Tilman Liege and Liege University, Liege, Belgium.
  • de Boer RH; Royal Melbourne Hospital, Victoria, Australia.
  • Hurvitz S; Jonsson Comprehensive Cancer Center, University of California, Los Angeles.
  • Yardley DA; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Kovalenko E; Tennessee Oncology, PLLC, Nashville, Tennessee.
  • Ejlertsen B; Russian Cancer Research Center, Moscow, Russia.
  • Blau S; Copenhagen University Hospital, Copenhagen, Denmark.
  • Özgüroglu M; Rainier Hematology-Oncology, Northwest Medical Specialties, Tacoma, Washington.
  • Landherr L; Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey.
  • Ewertz M; Uzsoki Teaching Hospital, Budapest, Hungary.
  • Taran T; Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
  • Fan J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Noel-Baron F; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Louveau AL; Novartis Pharma AG, Basel, Switzerland.
  • Burris H; Novartis Pharma SAS, Paris, France.
JAMA Oncol ; 4(10): 1367-1374, 2018 10 01.
Article em En | MEDLINE | ID: mdl-29862411

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrogênio / Everolimo / Capecitabina Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrogênio / Everolimo / Capecitabina Idioma: En Ano de publicação: 2018 Tipo de documento: Article